http://www.acorda.com
Acorda Therapeutics, Inc. Company Intro
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Industry
Healthcare
Acorda Therapeutics, Inc. Headquaters
420 Saw Mill River Road
Ardsley,10502
United States
Acorda Therapeutics, Inc. Share price
23 Oct 2020 01:01 GMT
$0.9468
0.01 (0.93 %)
Acorda Therapeutics, Inc. Market cap
$41.852 M
WMC RANKING
2020
Acorda Therapeutics, Inc. # 35
BiotechnologyLatest Acorda Therapeutics, Inc. News
22 Oct 2020
The Non Opioid Pain Patches market to stay attuned to growth ...
Some of the key payers of the non-opioid pain patches market are Pfizer Inc., Teikoku Seiyaku Co. Ltd., GlaxoSmithKline plc., Allergan Plc., Acorda Therapeutics ...
22 Oct 2020
With 55.32% Distance from Low, Is Acorda Therapeutics, Inc. (NASDAQ:ACOR) Poised For More Gains?
In last trading session, Acorda Therapeutics, Inc. (NASDAQ:ACOR) saw 7,648,217 shares changing hands with its beta currently measuring 1.29. Company's ...
22 Oct 2020
Do Acorda Therapeutics Inc. (ACOR) beta value of 1.29 ...
Acorda Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company's stock is recorded $2.7700 on ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Acorda Therapeutics, Inc. | 3.19 | 0 | 0 | 0 | 0 | 0 | 0.02 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 19 | 0 | 0 | 98.79 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 100 | 0 | 0 | 90.93 |
Acorda Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Acorda Therapeutics, Inc. | $176,370 | $263,752 | $-231,833 | $41.852M | 35 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.228B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $54.719B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.699B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.79B | 4 |